• Company News
• Industry News

Current Location：HomeNewsCompany News

04-15

2025

Efficacy and adverse effects of Bev/5-Fu combination therapy

Bevacizumab (bevacizumab, Avastin) is a recombinant human monoclonal IgG1 antibod...

Learn more

04-02

2025

【INVITATION】IATDMCT 2025 in Malaysia

The International Association of Therapeutic Drug Monitoring and Clinical Toxicol...

Learn more

03-31

2025

Diagreat invites you to visit our booth 7.1A08 at Shanghai CMEF

From April 8-11, 2025, the 91stChina International Medical Equipment Fair, the to...

Learn more

03-14

2025

Theophylline TDM: How to Protect Every Breath with Science?

TheoTheophyllines (Theo) are a class of methylxanthine derivatives with bronchodi...

Learn more

• All42page
• One page
• Previous
• ...
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• ...
• Next
• Last page